Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Medical Imaging

PUBLISHER: Grand View Research | PRODUCT CODE: 1908778

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1908778

Breast Imaging Market Size, Share & Trends Analysis Report By Technology (Ionizing, Non Ionizing), By End Use (Hospitals, Breast Care Centers, Diagnostic Imaging Centers), By Region, And Segment Forecasts, 2026 - 2033

PUBLISHED:
PAGES: 97 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Breast Imaging Market Summary

The global breast imaging market size was estimated at USD 5.88 billion in 2025 and is projected to reach USD 12.03 billion by 2033, growing at a CAGR of 9.7% from 2026 to 2033. Factors such as the rising prevalence of breast cancer, technological breakthroughs in the domain of breast imaging, and investment from several organizations in breast cancer screening programs drive the breast imaging market.

According to the World Cancer Research Fund (WCRF), by 2030, the number of cases of breast cancer is expected to reach about 2.1 million globally. According to a new report from the International Agency for Research on Cancer (IARC), breast cancer cases are expected to increase by 38 percent globally by 2050, with annual deaths from the disease projected to rise by 68 percent. This aspect is expected to contribute to the growth of the breast imaging market over the forecast period.

The growing prevalence of breast cancer and other breast-related abnormalities is expected to drive the expansion of the breast imaging market significantly. According to data published by the National Breast Cancer Foundation, Inc. in June 2025, approximately 1 in 8 women in the U.S. is expected to be diagnosed with breast cancer during their lifetime. In addition, projections from the International Agency for Research on Cancer estimate a 27.8% increase in breast cancer incidence in the U.S. between 2022 and 2050, with cases expected to reach approximately 350,693 by 2050. This substantial rise in cancer cases is anticipated to fuel the demand for breast magnetic resonance imaging procedures across the country.

Technological advancements are driving the growth of the breast imaging market, supported by increasing demand for earlier and more accurate cancer detection. Innovations such as molecular breast imaging, AI-assisted diagnostics, and enhanced breast imaging displays are improving clinical confidence and reducing interpretation challenges. As healthcare providers prioritize precision medicine and screening efficiency, these advanced tools continue to accelerate adoption and shape the future of breast cancer detection and care.

Widespread research in the development of hybrid imaging systems provides high growth opportunities and also aids the market growth. Recent developments in imaging technology have completely revolutionized the nature of treatment and how it is approached. To view the metabolic data and anatomical characteristics of the organs, it has become more crucial to combine imaging methods such as CT scans, MRIs, PET, and others. Furthermore, the quality of breast pictures, patient comfort, and patient dose have all been enhanced by these integrated imaging modalities. Thereby, owing to these advantages, manufacturers across the globe are concentrating more on the introduction of new products to improve the sensitivity and precision of breast cancer diagnostics. For instance, in February 2025, DeepHealth plans to introduce its Diagnostic Suite to the European market, offering a next-generation PACS system with a unified, workflow-optimized radiology workspace. The company also aims to expand access to SmartMammo, its AI-driven end-to-end mammography diagnostic solution, further integrating AI-enabled detection and clinical decision support into routine imaging workflows.

Global Breast Imaging Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global breast imaging market report based on technology, end use, and region:

  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Ionizing
    • Full-field Digital Mammography
    • Analog Mammography
    • Positron Emission Mammography
    • Electric Impedance Tomography
    • Cone-beam Computed Tomography
    • Positron Emission Tomography & Computed Tomography
    • 3D Breast Tomosynthesis
    • MBI/BSGI
  • Non Ionizing
    • MRI
    • Thermography
    • Ultrasound
    • Optical Imaging
    • Automated Whole-Breast Ultrasound
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Breast Care Centers
  • Diagnostic Imaging Centers
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
Show more
Product Code: 978-1-68038-146-7

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Technology
    • 1.1.2. End use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Breast Imaging Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growing prevalence of breast cancer
      • 3.2.1.2. Technological advancements in the field of breast imaging
      • 3.2.1.3. Investments and initiatives from various organizations in breast cancer screening campaigns
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Risk of adverse effects from radiation exposure
      • 3.2.2.2. High cost of imaging systems
    • 3.2.3. Market opportunity analysis
      • 3.2.3.1. Growing number of clinical trials
      • 3.2.3.2. Growing awareness of early detection
    • 3.2.4. Market challenge analysis
      • 3.2.4.1. Shortage of trained radiologists
  • 3.3. Breast Imaging Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. Breast Imaging Market: Technology Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Breast Imaging Market Technology Movement Analysis
  • 4.3. Global Breast Imaging Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
  • 4.4. Ionizing
    • 4.4.1. Ionizing market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.4.2. Full-Field Digital Mammography
      • 4.4.2.1. Full-field digital mammography market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.4.3. Analog Mammography
      • 4.4.3.1. Analog mammography market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.4.4. Positron Emission Mammography
      • 4.4.4.1. Positron emission mammography market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.4.5. Electric Impedance Tomography
      • 4.4.5.1. Electric impedance tomography market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.4.6. Cone-Beam Computed Tomography
      • 4.4.6.1. Cone-beam computed tomography market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.4.7. Positron Emission Tomography & Computed Tomography
      • 4.4.7.1. Positron emission tomography & computed tomography market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.4.8. 3D Breast Tomosynthesis
      • 4.4.8.1. 3D breast tomosynthesis market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.4.9. MBI/BSGI
      • 4.4.9.1. MBI/BSGI market estimates and forecasts for 2021 to 2033 (USD Million)
  • 4.5. Non Ionizing
    • 4.5.1. Non Ionizing market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.5.2. MRI
      • 4.5.2.1. MRI market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.5.3. Thermography
      • 4.5.3.1. Thermography market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.5.4. Ultrasound
      • 4.5.4.1. Ultrasound market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.5.5. Optical Imaging
      • 4.5.5.1. Optical imaging market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.5.6. Automated Whole-Breast Ultrasound
      • 4.5.6.1. Automated whole-breast ultrasound market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 5. Breast Imaging: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Breast Imaging Market End Use Movement Analysis
  • 5.3. Global Breast Imaging Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 5.4. Hospitals
    • 5.4.1. Hospitals market estimates and forecasts for 2021 to 2033 (USD Million)
  • 5.5. Diagnostic Imaging Centers
    • 5.5.1. Diagnostic imaging centers market estimates and forecasts for 2021 to 2033 (USD Million)
  • 5.6. Breast Care Centers
    • 5.6.1. Breast care centers market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 6. Breast Imaging Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Dashboard
  • 6.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
  • 6.3. North America
    • 6.3.1. Market estimates and forecast, 2021 - 2033 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Competitive scenario
      • 6.3.2.3. Regulatory framework
      • 6.3.2.4. Reimbursement scenario
      • 6.3.2.5. U.S. market estimates and forecasts, 2021 - 2033
    • 6.3.3. Canada
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Competitive scenario
      • 6.3.3.3. Regulatory framework
      • 6.3.3.4. Reimbursement scenario
      • 6.3.3.5. Canada market estimates and forecasts, 2021 - 2033
    • 6.3.4. Mexico
      • 6.3.4.1. Key country dynamics
      • 6.3.4.2. Competitive scenario
      • 6.3.4.3. Regulatory framework
      • 6.3.4.4. Reimbursement scenario
      • 6.3.4.5. Mexico market estimates and forecasts, 2021 - 2033
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Key country dynamics
      • 6.4.1.2. Competitive scenario
      • 6.4.1.3. Regulatory framework
      • 6.4.1.4. Reimbursement scenario
      • 6.4.1.5. UK market estimates and forecasts, 2021 - 2033
    • 6.4.2. Germany
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Competitive scenario
      • 6.4.2.3. Regulatory framework
      • 6.4.2.4. Reimbursement scenario
      • 6.4.2.5. Germany market estimates and forecasts, 2021 - 2033
    • 6.4.3. France
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Competitive scenario
      • 6.4.3.3. Regulatory framework
      • 6.4.3.4. Reimbursement scenario
      • 6.4.3.5. France market estimates and forecasts, 2021 - 2033
    • 6.4.4. Italy
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Competitive scenario
      • 6.4.4.3. Regulatory framework
      • 6.4.4.4. Reimbursement scenario
      • 6.4.4.5. Italy market estimates and forecasts, 2021 - 2033
    • 6.4.5. Spain
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Competitive scenario
      • 6.4.5.3. Regulatory framework
      • 6.4.5.4. Reimbursement scenario
      • 6.4.5.5. Spain market estimates and forecasts, 2021 - 2033
    • 6.4.6. Denmark
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Competitive scenario
      • 6.4.6.3. Regulatory framework
      • 6.4.6.4. Reimbursement scenario
      • 6.4.6.5. Denmark market estimates and forecasts, 2021 - 2033
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Competitive scenario
      • 6.4.7.3. Regulatory framework
      • 6.4.7.4. Reimbursement scenario
      • 6.4.7.5. Sweden market estimates and forecasts, 2021 - 2033
    • 6.4.8. Norway
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Competitive scenario
      • 6.4.8.3. Regulatory framework
      • 6.4.8.4. Reimbursement scenario
      • 6.4.8.5. Norway market estimates and forecasts, 2021 - 2033
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Competitive scenario
      • 6.5.1.3. Regulatory framework
      • 6.5.1.4. Reimbursement scenario
      • 6.5.1.5. Japan market estimates and forecasts, 2021 - 2033
    • 6.5.2. India
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Competitive scenario
      • 6.5.2.3. Regulatory framework
      • 6.5.2.4. Reimbursement scenario
      • 6.5.2.5. India market estimates and forecasts, 2021 - 2033
    • 6.5.3. China
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Competitive scenario
      • 6.5.3.3. Regulatory framework
      • 6.5.3.4. Reimbursement scenario
      • 6.5.3.5. China market estimates and forecasts, 2021 - 2033
    • 6.5.4. South Korea
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Competitive scenario
      • 6.5.4.3. Regulatory framework
      • 6.5.4.4. Reimbursement scenario
      • 6.5.4.5. South Korea market estimates and forecasts, 2021 - 2033
    • 6.5.5. Australia
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Competitive scenario
      • 6.5.5.3. Regulatory framework
      • 6.5.5.4. Reimbursement scenario
      • 6.5.5.5. Australia market estimates and forecasts, 2021 - 2033
    • 6.5.6. Thailand
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Competitive scenario
      • 6.5.6.3. Regulatory framework
      • 6.5.6.4. Reimbursement scenario
      • 6.5.6.5. Thailand market estimates and forecasts, 2021 - 2033
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Competitive scenario
      • 6.6.1.3. Regulatory framework
      • 6.6.1.4. Reimbursement scenario
      • 6.6.1.5. Brazil market estimates and forecasts, 2021 - 2033
    • 6.6.2. Argentina
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Competitive scenario
      • 6.6.2.3. Regulatory framework
      • 6.6.2.4. Reimbursement scenario
      • 6.6.2.5. Argentina market estimates and forecasts, 2021 - 2033
  • 6.7. MEA
    • 6.7.1. South Africa
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Competitive scenario
      • 6.7.1.3. Regulatory framework
      • 6.7.1.4. Reimbursement scenario
      • 6.7.1.5. South Africa market estimates and forecasts, 2021 - 2033
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Competitive scenario
      • 6.7.2.3. Regulatory framework
      • 6.7.2.4. Reimbursement scenario
      • 6.7.2.5. Saudi Arabia market estimates and forecasts, 2021 - 2033
    • 6.7.3. UAE
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Competitive scenario
      • 6.7.3.3. Regulatory framework
      • 6.7.3.4. Reimbursement scenario
      • 6.7.3.5. UAE market estimates and forecasts, 2021 - 2033
    • 6.7.4. Kuwait
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Competitive scenario
      • 6.7.4.3. Regulatory framework
      • 6.7.4.4. Reimbursement scenario
      • 6.7.4.5. Kuwait market estimates and forecasts, 2021 - 2033

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
    • 7.2.1. Innovators
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Global Key company market share analysis, 2024
    • 7.3.4. GE HealthCare
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Siemens Healthineers
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Philips Healthcare
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Hologic, Inc.
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Fujifilm Holdings Corp.
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. SonoCine, Inc.
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Toshiba Corporation (Canon Inc.)
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. Dilon Technologies, Inc.
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. SonoCine, Inc.
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Product benchmarking
      • 7.3.12.4. Strategic initiatives
    • 7.3.13. Aurora Imaging Technology, Inc.
      • 7.3.13.1. Company overview
      • 7.3.13.2. Financial performance
      • 7.3.13.3. Product benchmarking
      • 7.3.13.4. Strategic initiatives
  • 7.4. Heat Map Analysis/ Company Market Position Analysis
  • 7.5. Estimated Company Market Share Analysis, 2025
  • 7.6. List of Other Key Market Players
Show more
Product Code: 978-1-68038-146-7

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 North America breast imaging market, by country, 2021 - 2033 (USD million)
  • Table 4 North America breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 5 North America breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 6 U.S breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 7 U.S breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 8 Canada breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 9 Canada breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 10 Mexico breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 11 Mexcio breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 12 Europe breast imaging market, by country, 2021 - 2033 (USD million)
  • Table 13 Europe breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 14 Europe breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 15 UK breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 16 UK breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 17 Germany breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 18 Germany breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 19 France breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 20 France breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 21 Italy breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 22 Italy breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 23 Spain breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 24 Spain breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 25 Sweden breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 26 Sweden breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 27 Denmark breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 28 Denmark breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 29 Norway breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 30 Norway breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 31 Asia Pacific breast imaging market, by country, 2021 - 2033 (USD million)
  • Table 32 Asia Pacific breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 33 Asia Pacific breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 34 Japan breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 35 Japan breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 36 China breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 37 China breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 38 India breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 39 India breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 40 Australia breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 41 Australia breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 42 South Korea breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 43 South Korea breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 44 Thailand breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 45 Thailand breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 46 Latin America breast imaging market, by country, 2021 - 2033 (USD million)
  • Table 47 Latin America breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 48 Latin America breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 49 Brazil breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 50 Brazil breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 51 Argentina breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 52 Argentina breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 53 Middle East & Africa breast imaging market, by country, 2021 - 2033 (USD million)
  • Table 54 Middle East & Africa breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 55 Middle East & Africa breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 56 South Africa breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 57 South Africa breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 58 Saudi Arabia breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 59 Saudi Arabia breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 60 UAE breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 61 UAE breast imaging market, by end use, 2021 - 2033 (USD million)
  • Table 62 Kuwait breast imaging market, by technology, 2021 - 2033 (USD million)
  • Table 63 Kuwait breast imaging market, by end use, 2021 - 2033 (USD million)

List of Figures

  • Fig. 1 Breast imaging market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market summary (2025)
  • Fig. 10 Penetration & growth prospect mapping
  • Fig. 11 Reimbursement pathway
  • Fig. 12 Market driver relevance analysis (Current & future impact)
  • Fig. 13 Market restraint relevance analysis (Current & future impact)
  • Fig. 14 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 15 Porter's five forces analysis
  • Fig. 16 Breast imaging market: Technology movement analysis
  • Fig. 17 Breast imaging market technology outlook: Key takeaways
  • Fig. 18 Ionizing market, 2021 - 2033 (USD Million)
  • Fig. 19 Full-field digital mammography market, 2021 - 2033 (USD Million)
  • Fig. 20 Analog mammography market, 2021 - 2033 (USD Million)
  • Fig. 21 Positron emission mammography market, 2021 - 2033 (USD Million)
  • Fig. 22 Electric impedance tomography market, 2021 - 2033 (USD Million)
  • Fig. 23 Cone-beam computed tomography market, 2021 - 2033 (USD Million)
  • Fig. 24 Positron emission tomography & computed tomography market, 2021 - 2033 (USD Million)
  • Fig. 25 3D breast tomosynthesis market, 2021 - 2033 (USD Million)
  • Fig. 26 MBI/BSGI market, 2021 - 2033 (USD Million)
  • Fig. 27 Non Ionizing market, 2021 - 2033 (USD Million)
  • Fig. 28 MRI market, 2021 - 2033 (USD Million)
  • Fig. 29 Thermography market, 2021 - 2033 (USD Million)
  • Fig. 30 Ultrasound market, 2021 - 2033 (USD Million)
  • Fig. 31 Optical imaging market, 2021 - 2033 (USD Million)
  • Fig. 32 Automated whole-breast ultrasound market, 2021 - 2033 (USD Million)
  • Fig. 33 Breast imaging market: End use movement analysis
  • Fig. 34 Breast imaging market end use outlook: Key takeaways
  • Fig. 35 Ionizing market, 2021 - 2033 (USD Million)
  • Fig. 36 Hospitals market, 2021 - 2033 (USD Million)
  • Fig. 37 Diagnostic imaging centers market, 2021 - 2033 (USD Million)
  • Fig. 38 Breast care centers market, 2021 - 2033 (USD Million)
  • Fig. 39 Regional Outlook, 2025 & 2033
  • Fig. 40 Regional market: Key takeaways
  • Fig. 41 North America breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 42 U.S. breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 43 Canada breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 44 Europe breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 45 UK breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 46 Germany breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 47 France breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 48 Italy breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 49 Spain breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 50 Sweden breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 51 Denmark breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 52 Norway breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 53 Asia Pacific breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 54 Japan breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 55 China breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 56 India breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 57 Australia breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 58 South Korea breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 59 Thailand breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 60 Latin America breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 61 Brazil breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 62 Mexico breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 63 Argentina breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 64 Middle East & Africa breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 65 South Africa breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 66 Saudi Arabia breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 67 UAE breast imaging market, 2021 - 2033 (USD Million)
  • Fig. 68 Kuwait breast imaging market, 2021 - 2033 (USD Million)
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!